Friday, July 10, 2026

Drug profile · INN

rotavirus vaccine, live

rotavirus vaccine, live (ROTARIX) is a biological vaccine - induces immune response.

EMA: approved Antiinfectives for systemic use (J07) J07BH01
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — rotavirus vaccine, live
Class
Antiinfectives for systemic use (J07)
Route
Patents
0
Programs
3
Data quality
0.83

Quick answer

rotavirus vaccine, live (ROTARIX) is a biological vaccine - induces immune response.

Key facts

INN rotavirus vaccine, live
Brand ROTARIX
Mechanism Biological vaccine - induces immune response
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BH01

Mechanism of action

Biological vaccine - induces immune response

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. 217043 Phase 2 · GSK Glaxo Smith · Infections, Meningococcal
  2. Rotarix™ Phase 2 · GSK Glaxo Smith · Infections, Rotavirus
  3. VAN00013 Phase 2 · Sanofi-Aventis U.S · Meningococcal immunization

Related & competitor drugs

  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. colistimethate sodium Antiinfectives for systemic use (J01)
  3. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  4. daptomycin Antiinfectives for systemic use (J01)
  5. darunavir Antiinfectives for systemic use (J05)
  6. dengue tetravalent vaccine (live, attenuated) Antiinfectives for systemic use (J07)

Frequently asked questions

What is rotavirus vaccine, live?

rotavirus vaccine, live (ROTARIX) is a biological vaccine - induces immune response.

What is the brand name for rotavirus vaccine, live?

ROTARIX is a marketed brand name for rotavirus vaccine, live. Check FDA Drugs@FDA for the current US label holder and prescribing information.